NO20002149L - FremgangsmÕte for Õ redusere avhengighet hos pattedyr - Google Patents

FremgangsmÕte for Õ redusere avhengighet hos pattedyr

Info

Publication number
NO20002149L
NO20002149L NO20002149A NO20002149A NO20002149L NO 20002149 L NO20002149 L NO 20002149L NO 20002149 A NO20002149 A NO 20002149A NO 20002149 A NO20002149 A NO 20002149A NO 20002149 L NO20002149 L NO 20002149L
Authority
NO
Norway
Prior art keywords
addiction
procedure
reducing mammalian
mammal
reducing
Prior art date
Application number
NO20002149A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002149D0 (no
Inventor
Vicki Coffin
Paul Glue
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20002149D0 publication Critical patent/NO20002149D0/no
Publication of NO20002149L publication Critical patent/NO20002149L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20002149A 1997-10-28 2000-04-27 FremgangsmÕte for Õ redusere avhengighet hos pattedyr NO20002149L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95921397A 1997-10-28 1997-10-28
PCT/US1998/022255 WO1999021540A2 (fr) 1997-10-28 1998-10-26 Procede de reduction de l'appetence chez les mammiferes

Publications (2)

Publication Number Publication Date
NO20002149D0 NO20002149D0 (no) 2000-04-27
NO20002149L true NO20002149L (no) 2000-06-26

Family

ID=25501785

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002149A NO20002149L (no) 1997-10-28 2000-04-27 FremgangsmÕte for Õ redusere avhengighet hos pattedyr

Country Status (16)

Country Link
EP (1) EP1043980A2 (fr)
JP (1) JP2001520989A (fr)
KR (1) KR20010031470A (fr)
CN (1) CN1283116A (fr)
AR (1) AR015984A1 (fr)
AU (1) AU1110099A (fr)
BR (1) BR9814830A (fr)
CA (1) CA2308453A1 (fr)
CO (1) CO4970824A1 (fr)
HU (1) HUP0100115A2 (fr)
IL (1) IL135659A0 (fr)
NO (1) NO20002149L (fr)
PE (1) PE122299A1 (fr)
SK (1) SK5812000A3 (fr)
WO (1) WO1999021540A2 (fr)
ZA (1) ZA989786B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
PE20000333A1 (es) * 1998-03-02 2000-05-13 Schering Corp Metodo para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso y autismo
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
IL137937A0 (en) * 1999-08-27 2001-10-31 Pfizer Prod Inc A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
DE60231896D1 (de) 2001-11-05 2009-05-20 Krele Pharmaceuticals Llc Zusammensetzungen und verfahren zur erhöhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus
JP6355921B2 (ja) 2010-09-01 2018-07-11 トニックス ファーマスーティカルズ, インコーポレイテッドTONIX Pharmaceuticals, Inc. コカイン嗜癖の治療
AU2013289922B2 (en) 2012-07-12 2016-12-15 Psyadon Pharmaceuticals, Inc. Fused benzazepines for treatment of Tourette's Syndrome
SMT202000398T1 (it) * 2013-10-18 2020-09-10 Emalex Biosciences Inc Benzazepine fuse per il trattamento della balbuzie
CN110327350B (zh) * 2019-07-11 2021-02-23 温州医科大学 多巴胺d1受体拮抗剂sch39166在作为制备治疗眼部病理性血管新生药物的应用
CN110833621A (zh) * 2019-12-06 2020-02-25 中国医科大学 多巴胺受体1拮抗剂在制备治疗对氯胺酮致小鼠类精神分裂症药物上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607967A (en) * 1994-10-27 1997-03-04 Merck & Co., Inc. Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
AU3408097A (en) * 1996-06-06 1998-01-05 Ergo Research Corporation Treatment of lipid and glucose metabolism disorders with dopamine and seroto nin agonists

Also Published As

Publication number Publication date
WO1999021540B1 (fr) 1999-10-28
SK5812000A3 (en) 2000-12-11
HUP0100115A2 (hu) 2001-06-28
JP2001520989A (ja) 2001-11-06
AR015984A1 (es) 2001-05-30
WO1999021540A3 (fr) 1999-09-02
CA2308453A1 (fr) 1999-05-06
AU1110099A (en) 1999-05-17
ZA989786B (en) 1999-04-28
NO20002149D0 (no) 2000-04-27
EP1043980A2 (fr) 2000-10-18
PE122299A1 (es) 1999-12-04
CN1283116A (zh) 2001-02-07
IL135659A0 (en) 2001-05-20
KR20010031470A (ko) 2001-04-16
WO1999021540A2 (fr) 1999-05-06
CO4970824A1 (es) 2000-11-07
BR9814830A (pt) 2000-10-03

Similar Documents

Publication Publication Date Title
NO20002149L (no) FremgangsmÕte for Õ redusere avhengighet hos pattedyr
DK0542903T3 (da) Kokainreceptor-bindingsligander
BG102668A (en) Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
NO971288D0 (no) Sone-isolasjonsanordning innrettet til å plasseres i et borehull, samt fremgangsmåte for perforering av en formasjon som gjennomtrenges av et borehull
ID21020A (id) Komposisi aditif deterjen untuk bahan bakar diesel
NO962857D0 (no) Formasjons-injeksjonsverktöy for plassering in situ nede i et borehull
NO963742D0 (no) Fremgangsmåte til å stimulere hematopoese med hemaglobin
NO980729L (no) FremgangsmÕte for Õ nedsette syreinnholdet i rÕolje
FI884833A7 (fi) Polttoaineen suihkutusputki ja menetelmä sen valmistamiseksi
MY143582A (en) Antibodies to opgl
ATE214276T1 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
FI945251A7 (fi) Menetelmä häiriöiden havaitsemiseksi dieselmoottorien käynnissä
IL98574A0 (en) Piperidyl-substituted indoles
GR3026655T3 (en) Sequential removal of monosaccharides from the reducing end of oligosaccharides and uses thereof.
MX9606179A (es) Agonistas y antagonistas de los receptores del acido acetilcolina nicotinico de insectos para el control de endoparasitos.
DK0739354T3 (da) Præparater og fremgangsmåder, hvor der anvendes ikke-bundet MPL-receptor til stimulering af blodpladeproduktion
DE59610170D1 (de) Verfahren zum Herabsetzen der Ladungsträgerkonzentration zur Absenkung der Speicherladung in Halbleiterbauelementen durch zwei Implantationsstufen
Smith et al. Technical Brief No. 50: Sanitary Surveying
WO2000048622A3 (fr) Methode permettant l'inhibition de reactions inflammatoires
NO20006382L (no) Fremgangsmåte for behandling av organofosfatforgiftning
DK346387A (da) Fremgangsmaade til at reducere alkaliindholdet i cementklinker
AU7125998A (en) Method and system to locate leaks in subsurface containment structures using tracer gases
AU2910589A (en) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in the method
KR950027711U (ko) 암면 분사기
Kleingarn Structural Fire Protection Measures for Hot-Dip Galvanized Steel Structures

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application